CLASS ACTION UPDATE for IRTC, JFU and CLOV: Levi & Korsinsky, LLP Reminds Investors of Class Actions on Behalf of Shareholders

NEW YORK, NY / ACCESSWIRE / February 18, 2021 / Levi & Korsinsky, LLP announces that class action lawsuits have commenced on behalf of shareholders of the following publicly-traded companies. Shareholders interested in serving as lead plaintiff have until the deadlines listed to petition the court. Further details about the cases can be found at the links provided. There is no cost or obligation to you.

IRTC Shareholders Click Here: https://www.zlk.com/pslra-1/irhythm-technologies-inc-loss-form?prid=12994&wire=1
JFU Shareholders Click Here: https://www.zlk.com/pslra-1/9f-inc-information-request-form?prid=12994&wire=1
CLOV Shareholders Click Here: https://www.zlk.com/pslra-1/clover-health-investments-corp-loss-submission-form?prid=12994&wire=1

* ADDITIONAL INFORMATION BELOW *

iRhythm Technologies, Inc. (NASDAQ:IRTC)

IRTC Lawsuit on behalf of: investors who purchased August 4, 2020 - January 28, 2021
Lead Plaintiff Deadline: April 2, 2021
TO LEARN MORE, VISIT: https://www.zlk.com/pslra-1/irhythm-technologies-inc-loss-form?prid=12994&wire=1

According to the filed complaint, during the class period, iRhythm Technologies, Inc. made materially false and/or misleading statements and/or failed to disclose that: (1) iRhythm’s business would suffer as a result of the CMS’ rulemaking; (2) reimbursement rates would in fact plummet; (3) a lack of national pricing in the CMS rule and fee schedule would cause uncertainty and weakness in the Company’s business; and (4) as a result of the foregoing, Defendants’ public statements were materially false and misleading at all relevant times

9F Inc. (NASDAQ:JFU)

Lawsuit on behalf of investors who purchased JFU securities: (1) pursuant and/or traceable to the registration statement and related prospectus issued in connection with the Company's August 14, 2019 initial public offering; and/or (2) between August 14, 2019 and September 29, 2020.
Lead Plaintiff Deadline: March 22, 2021
TO LEARN MORE, VISIT: https://www.zlk.com/pslra-1/9f-inc-information-request-form?prid=12994&wire=1

According to the filed complaint, (1) the purported value and benefits of the Company’s financial institution partners and its tri-party cooperation business model did not in fact exist and/or were materially overstated, given that 9F and Property and Casualty Company Limited (“PICC”) had been engaged in an ongoing contractual dispute regarding payment of service fees under their cooperation agreement; (2) the collectability of service fees owed to 9F by PICC under the cooperation agreement was in doubt and at serious risk of non-payment; (3) there was a significant risk that PICC would no longer provide credit insurance and guarantee protection to investors and institutional funding partners; (4) as a result of the foregoing, the Company’s platform, business model, reputation and financial results had been materially impaired; and (5) as a result, Defendants’ statements about the Company’s business, operations, and prospects were materially false and misleading and/or lacked a reasonable basis at all relevant times.

Clover Health Investments, Corp. (NASDAQ:CLOV)

CLOV Lawsuit on behalf of: investors who purchased October 6, 2020 - February 3, 2021
Lead Plaintiff Deadline: April 6, 2021
TO LEARN MORE, VISIT: https://www.zlk.com/pslra-1/clover-health-investments-corp-loss-submission-form?prid=12994&wire=1

According to the filed complaint, during the class period, Clover Health Investments, Corp. made materially false and/or misleading statements and/or failed to disclose that: (i) Clover was the recipient of a Civil Investigative Demand from the DOJ; (ii) much of Clover’s sales are driven by a major related party deal that Clover not only failed to disclose but took active steps to conceal; (iii) Clover’s
subsidiary Seek Insurance failed to disclose its relationship with Clover and misled consumers as to its purported independence; (iv) Clover’s software was in fact rudimentary; and (v) as a result, the Company’s public statements were materially false and misleading at all relevant times.

You have until the lead plaintiff deadlines to request that the court appoint you as lead plaintiff. Your ability to share in any recovery doesn't require that you serve as a lead plaintiff.

Levi & Korsinsky is a nationally recognized firm with offices in New York, California, Connecticut, and Washington D.C. The firm's attorneys have extensive expertise and experience representing investors in securities litigation and have recovered hundreds of millions of dollars for aggrieved shareholders. Attorney advertising. Prior results do not guarantee similar outcomes.

CONTACT:
Levi & Korsinsky, LLP
Joseph E. Levi, Esq.
55 Broadway, 10th Floor
New York, NY 10006
jlevi@levikorsinsky.com
Tel: (212) 363-7500
Fax: (212) 363-7171
www.zlk.com

SOURCE: Levi & Korsinsky, LLP